The Federal Commission for the Protection against Sanitary Risks (Cofepris), published an alert for counterfeit Cialis in Mexico, which is offered for the care of erectile dysfunction and also works as a treatment for urinary symptoms associated with prostate enlargement, also known as benign prostatic hyperplasia.
The company that manufactures the drug reported that it does not recognize batches A91377K and C599653, presentation of 20 mg and 5 mg respectively, in the case of counterfeit products.
In addition to this, Cofepris reports that batch A890217K in a bottle is not authorized for Mexico and its . . .
